More about

Bisphosphonate

News
March 29, 2022
2 min read
Save

Risk for osteonecrosis of the jaw higher with denosumab vs. bisphosphonates

Risk for osteonecrosis of the jaw higher with denosumab vs. bisphosphonates

Adults with osteoporosis have a higher risk for developing osteonecrosis of the jaw with denosumab therapy compared with bisphosphonates, according to study findings published in the Journal of Bone and Mineral Research.

News
February 17, 2022
2 min read
Save

Benefits of bisphosphonates outweigh atypical femur fracture risk in women

Benefits of bisphosphonates outweigh atypical femur fracture risk in women

The reduced risks for osteoporotic and hip fractures with bisphosphonate therapy outweigh increased risk for atypical femur fractures for older women, according to study finding published in Bone.

News
November 22, 2021
3 min read
Save

Bisphosphonate therapy may prevent fracture in postmenopausal women with osteoporosis

Bisphosphonate therapy may prevent fracture in postmenopausal women with osteoporosis

Despite potential side effects, bisphosphonate therapy may benefit postmenopausal women with osteoporosis by preventing fractures, according to a study published in JAMA Internal Medicine.

News
October 14, 2021
2 min read
Save

Exercise builds bone strength during menopause

Exercise builds bone strength during menopause

Postmenopausal women with low bone mass saw greater gains in spine bone mineral density and less bone turnover when assigned monthly risedronate therapy compared with a 12-month regimen of impact and resistance exercises, study data show.

News
June 07, 2021
2 min read
Save

Osteoporosis drug initiation may lower mortality risk in adults with epilepsy

Osteoporosis drug initiation may lower mortality risk in adults with epilepsy

Adults with epilepsy who initiated any osteoporosis drug therapy had a lower 3-year mortality risk compared with those who did not take a medication, according to study data published in Bone.

News
May 07, 2021
2 min read
Save

Bisphosphonates may lower risk for invasive breast cancer among women with DCIS

Bisphosphonates may lower risk for invasive breast cancer among women with DCIS

Bisphosphonate use among women with a history of ductal carcinoma in situ appeared associated with lower risk for subsequent invasive breast cancer, according to study results published in Cancer Research.

News
March 12, 2021
3 min read
Save

Risk score created to identify atypical vs. typical femur fractures in women

Risk score created to identify atypical vs. typical femur fractures in women

A model factoring in age, femoral neck width and lateral cortical width at lesser trochanter may be able to differentiate atypical vs. typical femur fractures in women, according to study data.

News
February 04, 2021
2 min read
Save

CKD progression risk ‘modest’ with bisphosphonate use

CKD progression risk ‘modest’ with bisphosphonate use

Adults with chronic kidney disease stage 3b were more likely to experience a worsening of renal function when prescribed bisphosphonate therapy, according to a database analysis published in the Journal of Bone and Mineral Research.

News
September 01, 2020
3 min read
Save

Atypical femur fracture data support bisphosphonate ‘drug holiday’ after 5 years

Atypical femur fracture data support bisphosphonate ‘drug holiday’ after 5 years

Risk for atypical femur fractures with bisphosphonate therapy, while rare, was strongly associated with duration of use beyond about 5 years and was quickly and dramatically reduced after discontinuing, study data show.

News
June 04, 2020
3 min read
Save

Nitrogen-containing bisphosphonates reduce pneumonia risk, mortality after hip fracture

Nitrogen-containing bisphosphonates reduce pneumonia risk, mortality after hip fracture

Older adults prescribed nitrogen-containing bisphosphonate therapy after a hip fracture were less likely to develop pneumonia or die from the infection compared with similar adults who received no osteoporosis therapy, researchers report.

View more